The Vaccine Group, Ltd

The Vaccine Group, Ltd is rated 3 out of 5 in the category biotechnology. Read and write reviews about The Vaccine Group, Ltd. Our mission at The Vaccine Group (TVG) is to make the world a safer place by designing high-quality, effective animal vaccines to control existing and emerging infectious diseases in animals and the people they infect, both at a local and global scale. We aim to do this in a socially responsible fashion, adopting business strategies that are both financially sustainable and financially accessible. We believe the perfect vaccine is not only one that works well, but is also one that is used. Our strategy is to develop herpesvirus-based vaccine platforms for use in animals to protect them against infectious disease. These diseases include both economically important agricultural diseases, such as bovine tuberculosis in cattle and African swine fever in pigs, and zoonotic diseases that are transferred from animals to humans, such as Lassa fever. Most emerging infections, especially those with high pandemic potential in humans emerge from domestic and wildlife animal populations. Due to the ability to test animal vaccines in their intended host, and the relative speed at which animal compared to human vaccines are approved for use, direct vaccination of animals rather humans is becoming accepted as an approach to protect humans against some emerging zoonotic pathogens. Our platform technology is based on herpesvirus-based vaccine vectors for use in animals with the ability to ‘plug and play’ pathogen immunological target proteins in response to new pathogen threats.